Boston, September 30, 2026 / PRNewswire / -- Haemonetics Corporation (New York Stock Exchange ticker: HAE) announces that the company plans to release its financial results for the second quarter of fiscal year 2027 at 6:00 a.m. on Thursday, November 5, 2026, Eastern Time. The company will hold a teleconference with investors and analysts at 8:00 a.m. on November 5, 2026, to discuss the results and answer questions.
This teleconference can be accessed by calling: Q2 2027 Haemonetics Corporation Earnings Conference Call. After completing the registration, participants will receive a dial-in number as well as a unique PIN code to join the meeting. Although it is not mandatory, the company recommends that participants join 10 minutes before the event begins.
The live webcast of this teleconference can be watched through the Haemonetics Investor Relations website. Live webcast link: https://edge.media-server.com/mmc/p/kf8g7up6
Starting from 11:00 a.m. Eastern Time on November 5, 2026, the webcast link for the teleconference provided in this press release will also offer a replay of the teleconference and webcast, which will be available for one year.
About Haemonetics
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness, and efficiency of healthcare services. Its apheresis business boasts proprietary technologies aimed at enhancing the safety, collection yield, donor satisfaction, and operational efficiency for plasma and blood collection institutions worldwide. Its MedSurg business provides blood management technologies that support treatment decisions and optimize the management of blood products; it also offers interventional technologies, including advanced vascular closure systems and sensor-guided techniques, designed to improve surgical outcomes and enhance the patient experience. For more information, please visit www.haemonetics.com.
